(PDF) 383 Preclinical Safety and Pharmacology of KB105, an

383 Preclinical Safety and Pharmacology of KB105, an HSV-based Gene Therapy Vector for the Treatment of Autosomal Recessive Congenital Ichthyosis (ARCI)

Journal of Investigative Dermatology - United Kingdom

doi 10.1016/j.jid.2019.03.459

Full Text

Open PDF

Abstract

Available in full text

Date

May 1, 2019

Authors

Publisher

Elsevier BV

Related search

379 KB105: An HSV-based Gene Therapy Vector Engineered to Deliver Functional TGM1 to Autosomal Recessive Congenital Ichthyosis (ARCI) Keratinocytes

Journal of Investigative Dermatology

English

A Novel Missence Mutation in the Transglutaminase-1 Gene in an Autosomal Recessive Congenital Ichthyosis Patient

Journal of Integrative Cardiology

2020

English

Functional Study ofTGM1missense Mutations in Autosomal Recessive Congenital Ichthyosis

Experimental Dermatology

English

NIPAL4 Deletion Identified in an American Bully With Autosomal Recessive Congenital Ichthyosis and Response to Topical Therapy

Veterinary Medicine and Science

Veterinary

2019

English

Calpain 12 Function Revealed Through the Study of an Atypical Case of Autosomal Recessive Congenital Ichthyosis

Journal of Investigative Dermatology

English

102 Proteins Causing Autosomal Congenital Recessive Ichthyosis (ARCI) Colocalize in Differentiated Primary Keratinocytes and the Interactions Are Altered in Cells From Patients With TGM1 Mutations

Journal of Investigative Dermatology

English

Comparing Histopathology From Patients With X-Linked Recessive Ichthyosis and Autosomal Recessive Congenital Ichthyosis With Transglutaminase 1 Mutation: A Report From the National Registry for Ichthyosis and Related Skin Disorders

Journal of the American Academy of Dermatology

Dermatology

2016

English

Autosomal Recessive Congenital Ichthyosis: CERS3 Mutations Identified by a Next Generation Sequencing Panel Targeting Ichthyosis Genes

European Journal of Human Genetics

Genetics

2017

English

Transglutaminase 1 Mutations in Autosomal Recessive Congenital Ichthyosis: Private and Recurrent Mutations in an Isolated Population

American Journal of Human Genetics

Genetics

1997

English

Amanote Research

383 Preclinical Safety and Pharmacology of KB105, an HSV-based Gene Therapy Vector for the Treatment of Autosomal Recessive Congenital Ichthyosis (ARCI)

Journal of Investigative Dermatology - United Kingdom

doi 10.1016/j.jid.2019.03.459

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

379 KB105: An HSV-based Gene Therapy Vector Engineered to Deliver Functional TGM1 to Autosomal Recessive Congenital Ichthyosis (ARCI) Keratinocytes

A Novel Missence Mutation in the Transglutaminase-1 Gene in an Autosomal Recessive Congenital Ichthyosis Patient

Functional Study ofTGM1missense Mutations in Autosomal Recessive Congenital Ichthyosis

NIPAL4 Deletion Identified in an American Bully With Autosomal Recessive Congenital Ichthyosis and Response to Topical Therapy

Calpain 12 Function Revealed Through the Study of an Atypical Case of Autosomal Recessive Congenital Ichthyosis

102 Proteins Causing Autosomal Congenital Recessive Ichthyosis (ARCI) Colocalize in Differentiated Primary Keratinocytes and the Interactions Are Altered in Cells From Patients With TGM1 Mutations

Comparing Histopathology From Patients With X-Linked Recessive Ichthyosis and Autosomal Recessive Congenital Ichthyosis With Transglutaminase 1 Mutation: A Report From the National Registry for Ichthyosis and Related Skin Disorders

Autosomal Recessive Congenital Ichthyosis: CERS3 Mutations Identified by a Next Generation Sequencing Panel Targeting Ichthyosis Genes

Transglutaminase 1 Mutations in Autosomal Recessive Congenital Ichthyosis: Private and Recurrent Mutations in an Isolated Population